Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer

키워드

참고문헌 (81)

1. de Martel C, "Global burden of cancers attributable to infections in 2008: a review and synthetic analysis", Lancet Oncol, 13, pp.607~615 (2012)
2. Nomura A, "Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii", N Engl J Med, 325, pp.1132~1136 (1991)
3. Parsonnet J, "Helicobacter pylori infection and the risk of gastric carcinoma", N Engl J Med, 325, pp.1127~1131 (1991)
4. Schistosomes, "liver f lukes and Helicobacter pylori: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994", IARC Monogr Eval Carcinog Risks Hum, 61, pp.1~241 (1994)
5. Sugiyama A, "Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil", Cancer Res, 58, pp.2067~2069 (1998)
6. Watanabe T, "Helicobacter pylori infection induces gastric cancer in mongolian gerbils", Gastroenterology, 115, pp.642~648 (1998)
7. Helicobacter and Cancer Collaborative Group, "Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts", Gut, 49, pp.347~353 (2001)
8. Uemura N, "Helicobacter pylori infection and the development of gastric cancer", N Engl J Med, 345, pp.784~789 (2001)
9. 김상균, "한국인 헬리코박터 파일로리 감염의 진단과 치료 임상 진료지침 개정안 2013", 대한소화기학회지, 62(1), pp.3~26 (2013), 대한소화기학회
10. Liu WZ, "Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection", J Dig Dis, 14, pp.211~221 (2013)
11. Malfertheiner P, "Management of Helicobacter pylori infection: the Maastricht IV", Florence Consensus Report, 2012, pp.61, 646~664
12. Asaka M, "Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition", Helicobacter, 15, pp.1~20 (2010)
13. Fock KM, "Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection", J Gastroenterol Hepatol, 24, pp.1587~1600 (2009)
14. Chey WD, "Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection", Am J Gastroenterol, 102, pp.1808~1825 (2007)
15. Lee SY, "Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?", J Gastroenterol Hepatol, 27, pp.200~211 (2012)
16. Fukase K, "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial", Lancet, 372, pp.392~397 (2008)
17. Rokkas T, "The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis", Helicobacter, 12(2), pp.32~38 (2007)
18. Graham DY, "The time to eradicate gastric cancer is now", Gut, 54, pp.735~738 (2005)
19. Wong BC, "Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial", JAMA, 291, pp.187~194 (2004)
20. Graham DY, "Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally", Helicobacter, 11, pp.139~143 (2006)
21. You WC, "Randomized double- blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions", J Natl Cancer Inst, 98, pp.974~983 (2006)
22. Ma JL, "Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality", J Natl Cancer Inst, 104, pp.488~492 (2012)
23. Schmid CH, "Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials", Am J Ther, 6, pp.25~36 (1999)
24. Osborn JF, "How long will it take to reduce gastric cancer incidence by eradicating helicobacter pylori infection?", Cancer Prev Res, 6, pp.695~700 (2013)
25. Kato M, "Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group", Gut, 8 (2012)
26. Nasu J, "Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection", Endoscopy, 37, pp.990~993 (2005)
27. Uemura N, "Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer", Cancer Epidemiol Biomarkers Prev, 6, pp.639~642 (1997)
28. Malfertheiner P, "Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report", Aliment Pharmacol Ther, 16, pp.167~180 (2002)
29. Kato M, "Recent development of gastric cancer prevention", Jpn J Clin Oncol, 42, pp.987~994 (2012)
30. Choi J, "Helicobacter pylori eradication after endoscopic resection of gastric tumors", Gastroenterology, 142(5), pp.489~ (2012)
31. Maehata Y, "Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer", Gastrointest Endosc, 75, pp.39~46 (2012)
32. de Vries AC, "Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands", Gastroenterology, 134, pp.945~952 (2008)
33. Han JS, "A study of metachronous cancer after endoscopic resection of early gastric cancer", Scand J Gastroenterol, 46, pp.1099~1104 (2011)
34. Bae SE, "Effect of eradication of Helicobacter pylori on recurrence after endoscopic resection of gastric adenoma and early gastric cancer", Gastroenterology, 142(5), pp.183~ (2012)
35. Kim YI, "The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer", Gastroenterology, 144(5), pp.328~329 (2013)
36. O’Connor HJ, "Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis", Lancet, 2, pp.1178~1181 (1986)
37. Dixon MF, "Bile reflux gastritis and intestinal metaplasia at the cardia", Gut, 51, pp.351~355 (2002)
38. Cho SJ, "Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer", Aliment Pharmacol Ther, 38, pp.477~489 (2013)
39. Naylor GM, "Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients", Gut, 55, pp.1545~1552 (2006)
40. Abdullah M, "Helicobacter pylori infection and gastropathy: a comparison between Indonesian and Japanese patients", World J Gastroenterol, 15, pp.4928~4931 (2009)
41. Matsuhisa T, "Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence", Helicobacter, 17, pp.396~401 (2012)
42. Kim J, "Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer", PLoS One, 7, pp.29643~ (2012)
43. Shanks AM, "Helicobacter pylori infection, host genetics and gastric cancer", J Dig Dis, 10, pp.157~164 (2009)
44. Yamaoka Y, "Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains", Intern Med, 47, pp.1077~1083 (2008)
45. Nguyen LT, "Helicobacter pylori virulence and the diversity of gastric cancer in Asia", J Med Microbiol, 57, pp.1445~1453 (2008)
46. Kim N, "Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease", Helicobacter, 13, pp.245~255 (2008)
47. de Vries AC, "Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?", Am J Gastroenterol, 104, pp.1342~1345 (2009)
48. Yaghoobi M, "Family history and the risk of gastric cancer", Br J Cancer, 102, pp.237~242 (2010)
49. Shin CM, "Intrafamilial aggregation of gastric cancer: a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility", Eur J Gastroenterol Hepatol, 23, pp.411~417 (2011)
50. Rokkas T, "Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis", Eur J Gastroenterol Hepatol, 22, pp.1128~1133 (2010)
51. Nam JH, "Helicobacter pylori infection and histological changes in siblings of young gastric cancer patients", J Gastroenterol Hepatol, 26, pp.1157~1163 (2011)
52. Marcos-Pinto R, "First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA", OLGIM stages and dysplasia, 2012, pp.35, 1451~1459
53. Mabe K, "Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?", World J Gastroenterol, 15, pp.4290~4297 (2009)
54. Yanaoka K, "Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels", Int J Cancer, 125, pp.2697~2703 (2009)
55. Ogura K, "The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer", J Clin Gastroenterol, 42, pp.279~283 (2008)
56. Takenaka R, "Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type", Aliment Pharmacol Ther, 25, pp.805~812 (2007)
57. Take S, "Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases", J Gastroenterol, 42(17), pp.21~27 (2007)
58. Kato M, "Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer", Jpn J Clin Oncol, 40, pp.828~837 (2010)
59. Hansson LE, "The risk of stomach cancer in patients with gastric or duodenal ulcer disease", N Engl J Med, 335, pp.242~249 (1996)
60. Correa P, "Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy", J Natl Cancer Inst, 92, pp.1881~1888 (2000)
61. Saito D, "Impact of H. pylori eradication on gastric cancer prevention: endoscopic results of the Japanese Intervention Trial (JITHP-Study). a randomized multi-center trial", Gastroenterology, 128(4), pp.4~ (2005)
62. Zhou L., "Ten-year follow-up study on the incidence of gastric cancer and the pathological changes of gastric mucosa after H. pylori eradication in china", Gastroenterology, 134(4), pp.233~ (2008)
63. Meimarakis G, "Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study", Lancet Oncol, 7, pp.211~222 (2006)
64. Marrelli D, "Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer", Cancer, 115, pp.2071~2080 (2009)
65. Hoon Hur, "The Effects of Helicobacter pylori on the prognosis of patients with curatively resected gastric cancers in a population with high infection rate", 대한외과학회지, 83(4), pp.203~211 (2012), 대한외과학회
66. Wang F, "Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2,454 patients with gastric cancer", PLoS One, 8, pp.62440~ (2013)
67. Kwak HW, "Clinicopathological characteristics of gastric cancer according to the Helicobacter pylori infection status in a region of high prevalence of gastric cancer", Gastroenterology, 144(5), pp.325~ (2013)
68. Yoon H, "Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics", Helicobacter, 16, pp.382~388 (2011)
69. Kato S, "Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics", Cancer Sci, 98, pp.790~794 (2007)
70. Matsuo T, "Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese", Helicobacter, 16, pp.415~419 (2011)
71. Malfertheiner P, "Helicobacter pylori infection and current clinical areas of contention", Curr Opin Gastroenterol, 26, pp.618~623 (2010)
72. Yaghoobi M, "Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis", Am J Gastroenterol, 105, pp.1007~1013 (2010)
73. Cavaleiro-Pinto M, "Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis", Cancer Causes Control, 22, pp.375~387 (2011)
74. Blaser M., "Antibiotic overuse: stop the killing of beneficial bacteria", Nature, 476, pp.393~394 (2011)
75. Chen Y, "Association between Helicobacter pylori and mortality in the NHANES III study", Gut, 62, pp.1262~1269 (2013)
76. Manickam P, "Association of Helicobacter pylori seropositivity with all-cause mortality: fact or fiction?", Gut, 62, pp.1385~1386 (2013)
77. Asaka M, "Prevention of gastric cancer by Helicobacter pylori eradication", Intern Med, 49, pp.633~636 (2010)
78. Asaka M., "A new approach for elimination of gastric cancer deaths in Japan", Int J Cancer, 132, pp.1272~1276 (2013)
79. 이경숙, "Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008", Cancer Research and Treatment, 43(2), pp.83~88 (2011), 대한암학회
80. Nam SY, "Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees", Eur J Gastroenterol Hepatol, 21, pp.855~860 (2009)
81. Cho E, "Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea", Asian Pac J Cancer Prev, 14, pp.2533~2540 (2013)

관련 논문AI추천